Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Musser · SciRah

Researcher profile · Semantic Scholar

B. Musser

Share profile

B. Musser — researcher profile on SciRah

h-index: 27
Works: 68
Citations: 5,577

Most-cited papers

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
D. Weinreich, S. Sivapalasingam, Thomas D. Norton, Shazia Ali +29 more
2020New England Journal of Medicine1,489 citations Open access
Semantic Scholar
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
D. Weinreich, S. Sivapalasingam, T. Norton, Shazia Ali +36 more
2021New England Journal of Medicine549 citations Open access
Semantic Scholar
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
A. Baum, D. Ajithdoss, R. Copin, An-Bo Zhou +32 more
2020Science500 citations Open access
Semantic Scholar
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
M. O'Brien, E. Forleo-Neto, B. Musser, F. Isa +32 more
2021New England Journal of Medicine368 citations Open access
Semantic Scholar
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
T. Vilsbøll, J. Rosenstock, H. Yki-Järvinen, W. Cefalu +9 more
2010Diabetes, obesity and metabolism322 citations Open access
Semantic Scholar
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
D. Williams-Herman, S. Engel, E. Round, Jeremy R Johnson +6 more
2010BMC Endocrine Disorders269 citations Open access
Semantic Scholar
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
C. Addy, Hamish Wright, K. van Laere, I. Gantz +30 more
2008Cell Metabolism209 citations Open access
Semantic Scholar
Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.
N. Erondu, I. Gantz, B. Musser, S. Suryawanshi +19 more
2006Cell Metabolism175 citations Open access
Semantic Scholar
Missing Data in Randomized Clinical Trials for Weight Loss: Scope of the Problem, State of the Field, and Performance of Statistical Methods
Mai A. Elobeid, Miguel A. Padilla, Theresa McVie, Olivia Thomas +9 more
2009PLoS ONE171 citations Open access
Semantic Scholar
Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults.
I. Gantz, N. Erondu, M. Mallick, B. Musser +10 more
2007Journal of Clinical Endocrinology and Metabolism169 citations
Semantic Scholar
The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial
S. al Sifri, A. Basiounny, A. Echtay, M. Al Omari +13 more
2011International journal of clinical practice122 citations Open access
Semantic Scholar
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
Meagan P. O'Brien, E. Forleo-Neto, N. Sarkar, F. Isa +34 more
2022Journal of the American Medical Association (JAMA)98 citations Open access
Semantic Scholar
Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study
S. Aravind, K. Al Tayeb, S. B. Ismail, N. Shehadeh +11 more
2011Current Medical Research and Opinion95 citations
Semantic Scholar
Potent and Selective Agonism of the Melanocortin Receptor 4 With MK‐0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy
R. Krishna, B. Gumbiner, C. Stevens, B. Musser +17 more
2009Clinical pharmacology and therapy86 citations
Semantic Scholar
Single‐ and Multiple‐Dose Pharmacokinetics of Etoricoxib, a Selective Inhibitor of Cyclooxygenase‐2, in Man
N. Agrawal, A. Porras, C. Matthews, Mark J. Rose +9 more
2003Journal of clinical pharmacology86 citations
Semantic Scholar
Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events.
G. Geba, Da-Teng Li, Mengqi Xu, K. Mohammadi +3 more
2022Journal of Allergy and Clinical Immunology70 citations Open access
Semantic Scholar
Proof of Concept: A PhRMA Position Paper With Recommendations for Best Practice
M. Cartwright, S. Cohen, J. Fleishaker, S. Madani +3 more
2010Clinical pharmacology and therapy65 citations
Semantic Scholar
Interactions between Simvastatin and Troglitazone or Pioglitazone in Healthy Subjects
T. Prueksaritanont, J. Vega, Jamie J. Zhao, K. Gagliano +8 more
2001Journal of clinical pharmacology60 citations
Semantic Scholar
DB-OTO Gene Therapy for Inherited Deafness.
V. Valayannopoulos, M. Bance, Daniela Carvalho, John H. Greinwald +30 more
2025New England Journal of Medicine52 citations
Semantic Scholar
Effect of NPY5R Antagonist MK‐0557 on Weight Regain after Very‐low‐calorie Diet‐induced Weight Loss
N. Erondu, T. Wadden, I. Gantz, B. Musser +8 more
2007Obesity52 citations Open access
Semantic Scholar
The Biomarkers Consortium: Practice and Pitfalls of Open‐Source Precompetitive Collaboration
J. A. Wagner, M. Prince, E. Wright, M. M. Ennis +8 more
2010Clinical pharmacology and therapy51 citations
Semantic Scholar
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
M. Dirocco, E. Forleo-Neto, R. Pignolo, R. Keen +32 more
2023Nature Medicine50 citations Open access
Semantic Scholar
REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients
D. Weinreich, S. Sivapalasingam, T. Norton, S. Ali +36 more
2021medRxiv47 citations Open access
Semantic Scholar
Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy Is Demonstrated by Collaborative Pooling of Data From Clinical Trials Conducted by Multiple Sponsors
J. A. Wagner, E. C. Wright, M. M. Ennis, M. Prince +8 more
2009Clinical pharmacology and therapy47 citations
Semantic Scholar
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
Michael E. Dunn, A. Kithcart, Jee Hae Kim, A. Ho +188 more
2024Nature31 citations Open access
Semantic Scholar
NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine
N. Erondu, C. Addy, K. Lu, M. Mallick +12 more
2007Obesity29 citations Open access
Semantic Scholar
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial
G. Herman, Meagan P. O'Brien, E. Forleo-Neto, N. Sarkar +25 more
2022Lancet. Infectious Diseases (Print)27 citations Open access
Semantic Scholar
GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial
D. G. González Trotter, Stephen Donahue, Chris Wynne, Shazia Ali +15 more
2025Nature Communications25 citations Open access
Semantic Scholar
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention
M. P. O'Brien, E. Forleo Neto, B. Musser, F. Isa +33 more
2021medRxiv22 citations Open access
Semantic Scholar
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19
F. Isa, E. Forleo-Neto, Jonathan Meyer, Wen-Jun Zheng +26 more
2022International Journal of Infectious Diseases21 citations Open access
Semantic Scholar
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency
Judith Y. Altarejos, Jeffrey Pangilinan, S. Podgrabinska, B. Akıncı +33 more
2023Science Translational Medicine19 citations
Semantic Scholar
A Semi-mechanistic Model for the Effects of a Novel Glucagon Receptor Antagonist on Glucagon and the Interaction Between Glucose, Glucagon, and Insulin Applied to Adaptive Phase II Design
Joanna Z. Peng, William S. Denney, B. Musser, Rong-Qiong Liu +9 more
2014AAPS Journal19 citations Open access
Semantic Scholar
REGEN-COV Antibody Cocktail in Outpatients with Covid-19
D. Weinreich, S. Sivapalasingam, T. Norton, S. Ali +32 more
2021medRxiv17 citations Open access
Semantic Scholar
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial
Meagan P. O'Brien, Eduardo Forleo-Neto, N. Sarkar, F. Isa +33 more
2021medRxiv16 citations Open access
Semantic Scholar
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection
C. Portal-Celhay, E. Forleo-Neto, W. Eagan, B. Musser +25 more
2022JAMA Network Open15 citations Open access
Semantic Scholar
A Randomized Placebo-Controlled Trial of Sarilumab in Hospitalized Patients with Covid-19
S. Sivapalasingam, D. Lederer, R. Bhore, N. Hajizadeh +38 more
2021medRxiv15 citations Open access
Semantic Scholar
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial
S. Sivapalasingam, D. Lederer, R. Bhore, N. Hajizadeh +36 more
2022Clinical Infectious Diseases14 citations Open access
Semantic Scholar
A TWO-YEAR STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF TARANABANT IN OBESE PATIENTS: 52 WEEK RESULTS
R. D. Carr, I. Gantz, N. Erondu, M. Moreno +6 more
200814 citations
Semantic Scholar
Evaluation of the pharmacokinetics of digoxin in healthy subjects receiving etoricoxib.
J. Schwartz, N. Agrawal, M. Wehling, B. Musser +4 more
2008British Journal of Clinical Pharmacology13 citations Open access
Semantic Scholar
Repeat Subcutaneous Administration of REGEN-COV(R) in Adults is Well-Tolerated and Prevents the Occurrence of COVID-19
F. Isa, E. Forleo-Neto, J. Meyer, W. Zheng +27 more
2021medRxiv10 citations Open access
Semantic Scholar
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.
Christopher D Petro, A. Hooper, Avery Peace, K. Mohammadi +35 more
2024Science Translational Medicine9 citations
Semantic Scholar
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus
S. Sivapalasingam, G. A. Saviolakis, Kirsten A. Kulcsar, Aya Nakamura +14 more
2021Journal of Infectious Diseases8 citations Open access
Semantic Scholar
Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin
J. I. Schwartz, B. Musser, W. Tanaka, W. Taggart +3 more
2015Clinical pharmacology in drug development8 citations
Semantic Scholar
34-OR: The Effect of Combined Activin A and Myostatin Blockade on Body Composition—A Phase 1 Trial
D. G. González Trotter, Stephen Donahue, Chris Wynne, Shazia Ali +11 more
2024Diabetes7 citations
Semantic Scholar
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial.
F. Isa, A. G. González Ortiz, Jonathan Meyer, J. Hamilton +28 more
2024Lancet. Infectious Diseases (Print)6 citations
Semantic Scholar
Garetosmab, an inhibitor of activin A, reduces heterotopic ossification and flare-ups in adults with fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
M. Dirocco, E. Forleo-Neto, R. Pignolo, R. Keen +31 more
2023medRxiv4 citations Open access
Semantic Scholar
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection
Meng-Qi Xu, Meagan P. O'Brien, A. Hooper, E. Forleo-Neto +9 more
2023Open Forum Infectious Diseases4 citations Open access
Semantic Scholar
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles
Da-Teng Li, Mengqi Xu, A. Hooper, D. Rofail +8 more
2023Scientific Reports4 citations Open access
Semantic Scholar
Phase 2 dose-ranging study of the virologic efficacy and safety of the combination COVID-19 antibodies casirivimab and imdevimab in the outpatient setting
C. Portal Celhay, E. Forleo-Neto, W. Eagan, B. Musser +26 more
2021medRxiv4 citations Open access
Semantic Scholar
FRI058 Treatment With Mibavademab, A Novel Leptin Receptor Agonist, Is Associated With Improvement In Metabolic Parameters In Individuals With Generalized Lipodystrophy
Ben Olenchock, S. Podgrabinska, Christine Hou, B. Musser +20 more
2023Journal of the Endocrine Society3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Weinreich×20
Invite
D. Weinreich — researcher profile on SciRah
A. Hooper×17
Invite
A. Hooper — researcher profile on SciRah
A. Baum×14
Invite
A. Baum — researcher profile on SciRah
B. Kowal×14
Invite
B. Kowal — researcher profile on SciRah

×13

Invite

N. Stahl — researcher profile on SciRah

Invite

A. Mahmood — researcher profile on SciRah

Invite

K. Turner — researcher profile on SciRah

C. Kyratsous×12

Invite

C. Kyratsous — researcher profile on SciRah

N. Braunstein×12

Invite

N. Braunstein — researcher profile on SciRah

G. Yancopouloš×12

Invite

G. Yancopouloš — researcher profile on SciRah

Invite

L. Lipsich — researcher profile on SciRah

A. T. DiCioccio×10

Invite

A. T. DiCioccio — researcher profile on SciRah